GPT-5 lowers the cost of cell-free protein synthesis

OpenAI's GPT-5 combined with Ginkgo Bioworks' cloud automation has achieved a 40% cost reduction in cell-free protein synthesis through autonomous closed-loop experimentation. This breakthrough demonstrates AI's potential to optimize biotech processes, making protein production more efficient and economically viable for industrial applications.